Gottlieb Announces Four-Part FDA Plan on Antimicrobial Resistance

International Pharmaceutical Regulatory Monitor
A A
FDA Commissioner Scott Gottlieb announced a four-pronged agency initiative to take on antimicrobial resistance, in part by creating incentives for drugs that treat it.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00